Artiva Biotherapeutics, Inc. Common Stock ARTV
$4.27
-30.68%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (2 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $26.33
- Implied Upside
- +516.7%
- Price Target Range
- $4.00 – $40.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-27 | NeedhamGil Blum |
Downgrades | Buy → Hold | — |
| 2026-10-27 | WedbushDavid Nierengarten |
Downgrades | Outperform → Neutral | $40 → $4 |
| 2026-10-02 | Cantor FitzgeraldJosh Schimmer |
Reiterates | Overweight | $40 |
| 2026-06-08 | NeedhamGil Blum |
Reiterates | Buy | $41 |
| 2026-05-12 | NeedhamGil Blum |
Maintains | Buy | $18 → $41 |
| 2026-05-11 | Cantor FitzgeraldJosh Schimmer |
Maintains | Overweight | $10 → $40 |
| 2026-05-11 | WedbushMartin Fan |
Maintains | Outperform | $23 → $40 |
| 2026-05-08 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $15 → $35 |
| 2026-05-04 | NeedhamGil Blum |
Reiterates | Buy | $18 |
| 2026-03-11 | NeedhamGil Blum |
Reiterates | Buy | $18 |
| 2025-11-12 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $12 → $15 |
| 2025-10-17 | WedbushMartin Fan |
Maintains | Outperform | $18 → $23 |
| 2025-10-17 | NeedhamGil Blum |
Reiterates | Buy | $18 |
| 2025-06-11 | HC Wainwright & Co.Emily Bodnar |
Assumes | Buy | $12 |
| 2025-05-15 | NeedhamGil Blum |
Maintains | Buy | $23 → $18 |
| 2025-04-08 | NeedhamGil Blum |
Reiterates | Buy | $23 |
| 2025-03-26 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $20 |
| 2025-03-25 | WedbushMartin Fan |
Reiterates | Outperform | $18 |
| 2025-03-25 | Cantor FitzgeraldJosh Schimmer |
Maintains | Overweight | $23 → $20 |
| 2025-03-25 | NeedhamGil Blum |
Reiterates | Buy | $23 |
| 2024-12-30 | HC Wainwright & Co.Edward White |
Initiates coverage on | Buy | $20 |
| 2024-11-13 | NeedhamGil Blum |
Reiterates | Buy | $23 |
| 2024-08-30 | NeedhamGil Blum |
Reiterates | Buy | $23 |
| 2024-08-13 | NeedhamGil Blum |
Initiates coverage on | Buy | $23 |
| 2024-08-13 | WedbushDavid Nierengarten |
Initiates coverage on | Outperform | $18 |
| 2024-08-13 | Cantor FitzgeraldJosh Schimmer |
Initiates coverage on | Overweight | $23 |
| 2024-08-13 | TD CowenTyler Van Buren |
Initiates coverage on | Buy | — |
| 2024-08-13 | JefferiesKelly Shi |
Initiates coverage on | Buy | $21 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.27
- Market Cap
- $301.16 million
- 52-Week Range
- $2.52 – $14.53
- Average Volume
- 794K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.